Early Diagnosis of Multiple Sclerosis Based on Optical and Electrochemical Biosensors: Comprehensive Perspective

Izadi, S.; Nikseresht, A.; Sharifian, M.; Sahraian, M.A.; Hamidian Jahromi, A.; Aghighi, M.; Heidary, A. Significant increase in the prevalence of multiple sclerosis in iran in 2011. Iran. J. Med. Sci., 2014, 39(2), 152-153.
[PMID: 24644387]

Patsopoulos, N.A. Genetics of multiple sclerosis: an overview and new directions. Cold Spring Harb. Perspect. Med., 2018, 8(7)a028951
[http://dx.doi.org/10.1101/cshperspect.a028951] [PMID: 29440325]

Kurtzke, J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology, 1983, 33(11), 1444-1452.
[http://dx.doi.org/10.1212/WNL.33.11.1444] [PMID: 6685237]

Lublin, F.D.; Reingold, S.C. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology, 1996, 46(4), 907-911.
[http://dx.doi.org/10.1212/WNL.46.4.907] [PMID: 8780061]

Sanai, S.A.; Saini, V.; Benedict, R.H.; Zivadinov, R.; Teter, B.E.; Ramanathan, M.; Weinstock-Guttman, B. Aging and multiple sclerosis. Mult. Scler., 2016, 22(6), 717-725.
[http://dx.doi.org/10.1177/1352458516634871] [PMID: 26895718]

Harbo, H.F.; Gold, R.; Tintoré, M. Sex and gender issues in multiple sclerosis. Ther. Adv. Neurol. Disorder., 2013, 6(4), 237-248.
[http://dx.doi.org/10.1177/1756285613488434] [PMID: 23858327]

Sawcer, S.; Hellenthal, G.; Pirinen, M.; Spencer, C.C.; Patsopoulos, N.A.; Moutsianas, L.; Dilthey, A.; Su, Z.; Freeman, C.; Hunt, S.E.; Edkins, S.; Gray, E.; Booth, D.R.; Potter, S.C.; Goris, A.; Band, G.; Oturai, A.B.; Strange, A.; Saarela, J.; Bellenguez, C.; Fontaine, B.; Gillman, M.; Hemmer, B.; Gwilliam, R.; Zipp, F.; Jayakumar, A.; Martin, R.; Leslie, S.; Hawkins, S.; Giannoulatou, E.; D’alfonso, S.; Blackburn, H.; Martinelli Boneschi, F.; Liddle, J.; Harbo, H.F.; Perez, M.L.; Spurkland, A.; Waller, M.J.; Mycko, M.P.; Ricketts, M.; Comabella, M.; Hammond, N.; Kockum, I.; McCann, O.T.; Ban, M.; Whittaker, P.; Kemppinen, A.; Weston, P.; Hawkins, C.; Widaa, S.; Zajicek, J.; Dronov, S.; Robertson, N.; Bumpstead, S.J.; Barcellos, L.F.; Ravindrarajah, R.; Abraham, R.; Alfredsson, L.; Ardlie, K.; Aubin, C.; Baker, A.; Baker, K.; Baranzini, S.E.; Bergamaschi, L.; Bergamaschi, R.; Bernstein, A.; Berthele, A.; Boggild, M.; Bradfield, J.P.; Brassat, D.; Broadley, S.A.; Buck, D.; Butzkueven, H.; Capra, R.; Carroll, W.M.; Cavalla, P.; Celius, E.G.; Cepok, S.; Chiavacci, R.; Clerget-Darpoux, F.; Clysters, K.; Comi, G.; Cossburn, M.; Cournu-Rebeix, I.; Cox, M.B.; Cozen, W.; Cree, B.A.; Cross, A.H.; Cusi, D.; Daly, M.J.; Davis, E.; de Bakker, P.I.; Debouverie, M.; D’hooghe, M.B.; Dixon, K.; Dobosi, R.; Dubois, B.; Ellinghaus, D.; Elovaara, I.; Esposito, F.; Fontenille, C.; Foote, S.; Franke, A.; Galimberti, D.; Ghezzi, A.; Glessner, J.; Gomez, R.; Gout, O.; Graham, C.; Grant, S.F.; Guerini, F.R.; Hakonarson, H.; Hall, P.; Hamsten, A.; Hartung, H.P.; Heard, R.N.; Heath, S.; Hobart, J.; Hoshi, M.; Infante-Duarte, C.; Ingram, G.; Ingram, W.; Islam, T.; Jagodic, M.; Kabesch, M.; Kermode, A.G.; Kilpatrick, T.J.; Kim, C.; Klopp, N.; Koivisto, K.; Larsson, M.; Lathrop, M.; Lechner-Scott, J.S.; Leone, M.A.; Leppä, V.; Liljedahl, U.; Bomfim, I.L.; Lincoln, R.R.; Link, J.; Liu, J.; Lorentzen, A.R.; Lupoli, S.; Macciardi, F.; Mack, T.; Marriott, M.; Martinelli, V.; Mason, D.; McCauley, J.L.; Mentch, F.; Mero, I.L.; Mihalova, T.; Montalban, X.; Mottershead, J.; Myhr, K.M.; Naldi, P.; Ollier, W.; Page, A.; Palotie, A.; Pelletier, J.; Piccio, L.; Pickersgill, T.; Piehl, F.; Pobywajlo, S.; Quach, H.L.; Ramsay, P.P.; Reunanen, M.; Reynolds, R.; Rioux, J.D.; Rodegher, M.; Roesner, S.; Rubio, J.P.; Rückert, I.M.; Salvetti, M.; Salvi, E.; Santaniello, A.; Schaefer, C.A.; Schreiber, S.; Schulze, C.; Scott, R.J.; Sellebjerg, F.; Selmaj, K.W.; Sexton, D.; Shen, L.; Simms-Acuna, B.; Skidmore, S.; Sleiman, P.M.; Smestad, C.; Sørensen, P.S.; Søndergaard, H.B.; Stankovich, J.; Strange, R.C.; Sulonen, A.M.; Sundqvist, E.; Syvänen, A.C.; Taddeo, F.; Taylor, B.; Blackwell, J.M.; Tienari, P.; Bramon, E.; Tourbah, A.; Brown, M.A.; Tronczynska, E.; Casas, J.P.; Tubridy, N.; Corvin, A.; Vickery, J.; Jankowski, J.; Villoslada, P.; Markus, H.S.; Wang, K.; Mathew, C.G.; Wason, J.; Palmer, C.N.; Wichmann, H.E.; Plomin, R.; Willoughby, E.; Rautanen, A.; Winkelmann, J.; Wittig, M.; Trembath, R.C.; Yaouanq, J.; Viswanathan, A.C.; Zhang, H.; Wood, N.W.; Zuvich, R.; Deloukas, P.; Langford, C.; Duncanson, A.; Oksenberg, J.R.; Pericak-Vance, M.A.; Haines, J.L.; Olsson, T.; Hillert, J.; Ivinson, A.J.; De Jager, P.L.; Peltonen, L.; Stewart, G.J.; Hafler, D.A.; Hauser, S.L.; McVean, G.; Donnelly, P.; Compston, A. International Multiple Sclerosis Genetics ConsortiumWellcome Trust Case Control Consortium 2. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature, 2011, 476(7359), 214-219.
[http://dx.doi.org/10.1038/nature10251] [PMID: 21833088]

Beecham, A.H.; Patsopoulos, N.A.; Xifara, D.K.; Davis, M.F.; Kemppinen, A.; Cotsapas, C.; Shah, T.S.; Spencer, C.; Booth, D.; Goris, A.; Oturai, A.; Saarela, J.; Fontaine, B.; Hemmer, B.; Martin, C.; Zipp, F.; D’Alfonso, S.; Martinelli-Boneschi, F.; Taylor, B.; Harbo, H.F.; Kockum, I.; Hillert, J.; Olsson, T.; Ban, M.; Oksenberg, J.R.; Hintzen, R.; Barcellos, L.F.; Agliardi, C.; Alfredsson, L.; Alizadeh, M.; Anderson, C.; Andrews, R.; Søndergaard, H.B.; Baker, A.; Band, G.; Baranzini, S.E.; Barizzone, N.; Barrett, J.; Bellenguez, C.; Bergamaschi, L.; Bernardinelli, L.; Berthele, A.; Biberacher, V.; Binder, T.M.; Blackburn, H.; Bomfim, I.L.; Brambilla, P.; Broadley, S.; Brochet, B.; Brundin, L.; Buck, D.; Butzkueven, H.; Caillier, S.J.; Camu, W.; Carpentier, W.; Cavalla, P.; Celius, E.G.; Coman, I.; Comi, G.; Corrado, L.; Cosemans, L.; Cournu-Rebeix, I.; Cree, B.A.; Cusi, D.; Damotte, V.; Defer, G.; Delgado, S.R.; Deloukas, P.; di Sapio, A.; Dilthey, A.T.; Donnelly, P.; Dubois, B.; Duddy, M.; Edkins, S.; Elovaara, I.; Esposito, F.; Evangelou, N.; Fiddes, B.; Field, J.; Franke, A.; Freeman, C.; Frohlich, I.Y.; Galimberti, D.; Gieger, C.; Gourraud, P.A.; Graetz, C.; Graham, A.; Grummel, V.; Guaschino, C.; Hadjixenofontos, A.; Hakonarson, H.; Halfpenny, C.; Hall, G.; Hall, P.; Hamsten, A.; Harley, J.; Harrower, T.; Hawkins, C.; Hellenthal, G.; Hillier, C.; Hobart, J.; Hoshi, M.; Hunt, S.E.; Jagodic, M.; Jelčić, I.; Jochim, A.; Kendall, B.; Kermode, A.; Kilpatrick, T.; Koivisto, K.; Konidari, I.; Korn, T.; Kronsbein, H.; Langford, C.; Larsson, M.; Lathrop, M.; Lebrun-Frenay, C.; Lechner-Scott, J.; Lee, M.H.; Leone, M.A.; Leppä, V.; Liberatore, G.; Lie, B.A.; Lill, C.M.; Lindén, M.; Link, J.; Luessi, F.; Lycke, J.; Macciardi, F.; Männistö, S.; Manrique, C.P.; Martin, R.; Martinelli, V.; Mason, D.; Mazibrada, G.; McCabe, C.; Mero, I.L.; Mescheriakova, J.; Moutsianas, L.; Myhr, K.M.; Nagels, G.; Nicholas, R.; Nilsson, P.; Piehl, F.; Pirinen, M.; Price, S.E.; Quach, H.; Reunanen, M.; Robberecht, W.; Robertson, N.P.; Rodegher, M.; Rog, D.; Salvetti, M.; Schnetz-Boutaud, N.C.; Sellebjerg, F.; Selter, R.C.; Schaefer, C.; Shaunak, S.; Shen, L.; Shields, S.; Siffrin, V.; Slee, M.; Sorensen, P.S.; Sorosina, M.; Sospedra, M.; Spurkland, A.; Strange, A.; Sundqvist, E.; Thijs, V.; Thorpe, J.; Ticca, A.; Tienari, P.; van Duijn, C.; Visser, E.M.; Vucic, S.; Westerlind, H.; Wiley, J.S.; Wilkins, A.; Wilson, J.F.; Winkelmann, J.; Zajicek, J.; Zindler, E.; Haines, J.L.; Pericak-Vance, M.A.; Ivinson, A.J.; Stewart, G.; Hafler, D.; Hauser, S.L.; Compston, A.; McVean, G.; De Jager, P.; Sawcer, S.J.; McCauley, J.L. International Multiple Sclerosis Genetics Consortium (IMSGC); Wellcome Trust Case Control Consortium 2 (WTCCC2); International IBD Genetics Consortium (IIBDGC). Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet., 2013, 45(11), 1353-1360.
[http://dx.doi.org/10.1038/ng.2770] [PMID: 24076602]

Luczynski, P.; Laule, C.; Hsiung, G.R.; Moore, G.R.W.; Tremlett, H. Coexistence of Multiple Sclerosis and Alzheimer’s disease: A review. Mult. Scler. Relat. Disord., 2019, 27, 232-238.
[http://dx.doi.org/10.1016/j.msard.2018.10.109] [PMID: 30415025]

Ebers, G.C.; Sadovnick, A.D.; Risch, N.J. Canadian Collaborative Study Group. A genetic basis for familial aggregation in multiple sclerosis. Nature, 1995, 377(6545), 150-151.
[http://dx.doi.org/10.1038/377150a0] [PMID: 7675080]

Sadovnick, A.D.; Ebers, G.C.; Dyment, D.A.; Risch, N.J.; Group, C.C.S. The Canadian Collaborative Study Group. Evidence for genetic basis of multiple sclerosis. Lancet, 1996, 347(9017), 1728-1730.
[http://dx.doi.org/10.1016/S0140-6736(96)90807-7] [PMID: 8656905]

Housley, W.J.; Pitt, D.; Hafler, D.A. Biomarkers in multiple sclerosis. Clin. Immunol., 2015, 161(1), 51-58.
[http://dx.doi.org/10.1016/j.clim.2015.06.015] [PMID: 26143623]

Lublin, F.D. New multiple sclerosis phenotypic classification. Eur. Neurol., 2014, 72(Suppl. 1), 1-5.
[http://dx.doi.org/10.1159/000367614] [PMID: 25278115]

Kavaliunas, A.; Manouchehrinia, A.; Danylaite Karrenbauer, V.; Gyllensten, H.; Glaser, A.; Alexanderson, K.; Hillert, J. Income in multiple sclerosis patients with different disease phenotypes. PLoS One, 2017, 12(1)e0169460
[http://dx.doi.org/10.1371/journal.pone.0169460] [PMID: 28081163]

Rovaris, M.; Confavreux, C.; Furlan, R.; Kappos, L.; Comi, G.; Filippi, M. Secondary progressive multiple sclerosis: current knowledge and future challenges. Lancet Neurol., 2006, 5(4), 343-354.
[http://dx.doi.org/10.1016/S1474-4422(06)70410-0] [PMID: 16545751]

Webb, E.J.; Meads, D.; Eskyte, I.; King, N.; Dracup, N.; Chataway, J.; Ford, H.L.; Marti, J.; Pavitt, S.H.; Schmierer, K. A Systematic Review of Discrete-Choice Experiments and Conjoint Analysis Studies in People with Multiple Sclerosis; The Patient-Patient-Centered Outcomes Research, 2018, pp. 1-12.

Lassmann, H.; van Horssen, J.; Mahad, D. Progressive multiple sclerosis: pathology and pathogenesis. Nat. Rev. Neurol., 2012, 8(11), 647-656.
[http://dx.doi.org/10.1038/nrneurol.2012.168] [PMID: 23007702]

Ebers, G. C. Natural history of primary progressive multiple sclerosis. Mult. Scler. J., 2004, 10(3_suppl), S8-S15.

Stork, L.; Ellenberger, D.; Beißbarth, T.; Friede, T.; Lucchinetti, C.F.; Brück, W.; Metz, I. Differences in the reponses to apheresis therapy of patients with 3 histopathologically classified immunopathological patterns of multiple sclerosis. JAMA Neurol., 2018, 75(4), 428-435.
[http://dx.doi.org/10.1001/jamaneurol.2017.4842] [PMID: 29404583]

Verhey, L.H. MRI in the Prediction and Diagnosis of Pediatric- Onset Multiple Sclerosis: Insights from Children with Incident CNS De-myelination.. PhD Thesis, University of Toronto: Toronto. 2012.

Nandoskar, A.; Raffel, J.; Scalfari, A.S.; Friede, T.; Nicholas, R.S. Pharmacological approaches to the management of secondary progressive multiple sclerosis. Drugs, 2017, 77(8), 885-910.
[http://dx.doi.org/10.1007/s40265-017-0726-0] [PMID: 28429241]

Miller, D.; Barkhof, F.; Montalban, X.; Thompson, A.; Filippi, M. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol., 2005, 4(5), 281-288.
[http://dx.doi.org/10.1016/S1474-4422(05)70071-5] [PMID: 15847841]

Gunnarsson, M.; Malmeström, C.; Axelsson, M.; Sundström, P.; Dahle, C.; Vrethem, M.; Olsson, T.; Piehl, F.; Norgren, N.; Rosengren, L.; Svenningsson, A.; Lycke, J. Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab. Ann. Neurol., 2011, 69(1), 83-89.
[http://dx.doi.org/10.1002/ana.22247] [PMID: 21280078]

Jones, J.L.; Anderson, J.M.; Phuah, C-L.; Fox, E.J.; Selmaj, K.; Margolin, D.; Lake, S.L.; Palmer, J.; Thompson, S.J.; Wilkins, A.; Webber, D.J.; Compston, D.A.; Coles, A.J. Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity. Brain, 2010, 133(Pt 8), 2232-2247.
[http://dx.doi.org/10.1093/brain/awq176] [PMID: 20659956]

Petzold, A. Biomarkers of disease progression.Progressive Multiple Sclerosis; Springer, 2018, pp. 123-154.
[http://dx.doi.org/10.1007/978-3-319-65921-3_6]

Igra, M.S.; Paling, D.; Wattjes, M.P.; Connolly, D.J.A.; Hoggard, N. Multiple sclerosis update: use of MRI for early diagnosis, disease monitoring and assessment of treatment related complications. Br. J. Radiol., 2017, 90(1074)20160721
[http://dx.doi.org/10.1259/bjr.20160721] [PMID: 28362522]

Brownlee, W.J.; Swanton, J.K.; Altmann, D.R.; Ciccarelli, O.; Miller, D.H. Earlier and more frequent diagnosis of multiple sclerosis using the McDonald criteria. J. Neurol. Neurosurg. Psychiatry, 2015, 86(5), 584-585.
[http://dx.doi.org/10.1136/jnnp-2014-308675] [PMID: 25412872]

Dixon, C.; Robertson, D. To diagnose or not to diagnose? Timing is the question: balancing early diagnosis of multiple sclerosis with misdiagnosis; Taylor & Francis, 2018.

Traboulsee, A.; Simon, J.; Stone, L.; Fisher, E.; Jones, D.; Malhotra, A.; Newsome, S.; Oh, J.; Reich, D.; Richert, N. Revised recommendations of the consortium of MS centers task force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis. AJNR Am. J. Neuroradiol., 2016, 37(3), 394-401.
[PMID: 26564433]

Puthenparampil, M.; Federle, L.; Poggiali, D.; Miante, S.; Signori, A.; Pilotto, E.; Rinaldi, F.; Perini, P.; Sormani, M.P.; Midena, E.; Gallo, P. Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis. PLoS One, 2017, 12(8)e0183957
[http://dx.doi.org/10.1371/journal.pone.0183957] [PMID: 28850630]

Derkus, B.; Acar Bozkurt, P.; Tulu, M.; Emregul, K.C.; Yucesan, C.; Emregul, E. Simultaneous quantification of Myelin Basic Protein and Tau proteins in cerebrospinal fluid and serum of Multiple Sclerosis patients using nanoimmunosensor. Biosens. Bioelectron., 2017, 89(Pt 2), 781-788.
[http://dx.doi.org/10.1016/j.bios.2016.10.019] [PMID: 27816592]

Shui, B.; Tao, D.; Florea, A.; Cheng, J.; Zhao, Q.; Gu, Y.; Li, W.; Jaffrezic-Renault, N.; Mei, Y.; Guo, Z. Biosensors for Alzheimer’s disease biomarker detection: A review. Biochimie, 2018, 147, 13-24.
[http://dx.doi.org/10.1016/j.biochi.2017.12.015] [PMID: 29307704]

Thompson, A.J.; Banwell, B.L.; Barkhof, F.; Carroll, W.M.; Coetzee, T.; Comi, G.; Correale, J.; Fazekas, F.; Filippi, M.; Freedman, M.S. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol., 2018, 17(2), 162-173.
[PMID: 29275977]

Milo, R.; Miller, A. Revised diagnostic criteria of multiple sclerosis. Autoimmun. Rev., 2014, 13(4-5), 518-524.
[http://dx.doi.org/10.1016/j.autrev.2014.01.012] [PMID: 24424194]

Rovira, À.; Wattjes, M.P.; Tintoré, M.; Tur, C.; Yousry, T.A.; Sormani, M.P.; De Stefano, N.; Filippi, M.; Auger, C.; Rocca, M.A.; Barkhof, F.; Fazekas, F.; Kappos, L.; Polman, C.; Miller, D.; Montalban, X. MAGNIMS study group. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process. Nat. Rev. Neurol., 2015, 11(8), 471-482.
[http://dx.doi.org/10.1038/nrneurol.2015.106] [PMID: 26149978]

Graus, F.; Titulaer, M.J.; Balu, R.; Benseler, S.; Bien, C.G.; Cellucci, T.; Cortese, I.; Dale, R.C.; Gelfand, J.M.; Geschwind, M.; Glaser, C.A.; Honnorat, J.; Höftberger, R.; Iizuka, T.; Irani, S.R.; Lancaster, E.; Leypoldt, F.; Prüss, H.; Rae-Grant, A.; Reindl, M.; Rosenfeld, M.R.; Rostásy, K.; Saiz, A.; Venkatesan, A.; Vincent, A.; Wandinger, K.P.; Waters, P.; Dalmau, J. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol., 2016, 15(4), 391-404.
[http://dx.doi.org/10.1016/S1474-4422(15)00401-9] [PMID: 26906964]

Katz Sand, I. Classification, diagnosis, and differential diagnosis of multiple sclerosis. Curr. Opin. Neurol., 2015, 28(3), 193-205.
[http://dx.doi.org/10.1097/WCO.0000000000000206] [PMID: 25887774]

Hinsinger, G.; Galéotti, N.; Nabholz, N.; Urbach, S.; Rigau, V.; Demattei, C.; Lehmann, S.; Camu, W.; Labauge, P.; Castelnovo, G.; Brassat, D.; Loussouarn, D.; Salou, M.; Laplaud, D.; Casez, O.; Bockaert, J.; Marin, P.; Thouvenot, E. Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis. Mult. Scler., 2015, 21(10), 1251-1261.
[http://dx.doi.org/10.1177/1352458514561906] [PMID: 25698171]

Katz Sand, I.; Krieger, S.; Farrell, C.; Miller, A.E. Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis. Mult. Scler., 2014, 20(12), 1654-1657.
[http://dx.doi.org/10.1177/1352458514521517] [PMID: 24493475]

Marrie, R.A.; Patten, S.B.; Tremlett, H.; Wolfson, C.; Warren, S.; Svenson, L.W.; Jette, N.; Fisk, J. CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis. Sex differences in comorbidity at diagnosis of multiple sclerosis: A populationbased study. Neurology, 2016, 86(14), 1279-1286.
[http://dx.doi.org/10.1212/WNL.0000000000002481] [PMID: 26962066]

Mittal, S.; Kaur, H.; Gautam, N.; Mantha, A.K. Biosensors for breast cancer diagnosis: A review of bioreceptors, biotransducers and signal amplification strategies. Biosens. Bioelectron., 2017, 88, 217-231.
[http://dx.doi.org/10.1016/j.bios.2016.08.028] [PMID: 27567264]

Parsa, S.F.; Vafajoo, A.; Rostami, A.; Salarian, R.; Rabiee, M.; Rabiee, N.; Rabiee, G.; Tahriri, M.; Yadegari, A.; Vashaee, D.; Tayebi, L.; Hamblin, M.R. Early diagnosis of disease using microbead array technology: A review. Anal. Chim. Acta, 2018, 1032, 1-17.
[http://dx.doi.org/10.1016/j.aca.2018.05.011] [PMID: 30143206]

Nasseri, B.; Soleimani, N.; Rabiee, N.; Kalbasi, A.; Karimi, M.; Hamblin, M.R. Point-of-care microfluidic devices for pathogen detection. Biosens. Bioelectron., 2018, 117, 112-128.
[http://dx.doi.org/10.1016/j.bios.2018.05.050] [PMID: 29890393]

Ghasemi, A.; Rabiee, N.; Ahmadi, S.; Hashemzadeh, S.; Lolasi, F.; Bozorgomid, M.; Kalbasi, A.; Nasseri, B.; Shiralizadeh Dezfuli, A.; Aref, A.R.; Karimi, M.; Hamblin, M.R. Optical assays based on colloidal inorganic nanoparticles. Analyst (Lond.), 2018, 143(14), 3249-3283.
[http://dx.doi.org/10.1039/C8AN00731D] [PMID: 29924108]

Rabiee, N.; Safarkhani, M.; Rabiee, M. Ultra-sensitive electrochemical on-line determination of Clarithromycin based on Poly (L-Aspartic Acid)/Graphite Oxide/Pristine Graphene/Glassy Carbon Electrode. Asian Journal of Nanosciences and Materials, 2018, 1, 61-70.

Ahmadi, S.; Rabiee, N.; Rabiee, M. Application of Aptamer-based hybrid molecules in Early Diagnosis and Treatment of Diabetes Mellitus: From the Concepts toward the Future. Curr. Diabetes Rev., 2018.
[PMID: 29875005]

Magliozzi, R.; Howell, O.W.; Nicholas, R.; Cruciani, C.; Castellaro, M.; Romualdi, C.; Rossi, S.; Pitteri, M.; Benedetti, M.D.; Gajofatto, A.; Pizzini, F.B.; Montemezzi, S.; Rasia, S.; Capra, R.; Bertoldo, A.; Facchiano, F.; Monaco, S.; Reynolds, R.; Calabrese, M. Inflammatory intrathecal profiles and cortical damage in multiple sclerosis. Ann. Neurol., 2018, 83(4), 739-755.
[http://dx.doi.org/10.1002/ana.25197] [PMID: 29518260]

Thompson, S.B.N.; Coleman, A.; Williams, N. Yawning and cortisol levels in multiple sclerosis: Potential new diagnostic tool. Mult. Scler. Relat. Disord., 2018, 23, 51-55.
[http://dx.doi.org/10.1016/j.msard.2018.04.019] [PMID: 29772467]

Wallin, M.T.; Culpepper, W.J.; Maloni, H.; Kurtzke, J.F. The Gulf War era multiple sclerosis cohort: 3. Early clinical features. Acta Neurol. Scand., 2018, 137(1), 76-84.
[http://dx.doi.org/10.1111/ane.12810] [PMID: 28832890]

Cerqueira, J. J.; Compston, D. A. S.; Geraldes, R.; Rosa, M. M.; Schmierer, K.; Thompson, A.; Tinelli, M.; Palace, J. Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis? J Neurol Neurosurg Psychiatry, 2018. jnnp-2017-317509
[http://dx.doi.org/10.1136/jnnp-2017-317509]

Cervantes-Gracia, K.; Husi, H. Integrative analysis of Multiple Sclerosis using a systems biology approach. Sci. Rep., 2018, 8(1), 5633.
[http://dx.doi.org/10.1038/s41598-018-24032-8] [PMID: 29618802]

Oakley, R.H.; Cidlowski, J.A. The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J. Allergy Clin. Immunol., 2013, 132(5), 1033-1044.
[http://dx.doi.org/10.1016/j.jaci.2013.09.007] [PMID: 24084075]

Zhou, P.; Pang, D.; Li, W. Transducer for embedded bio-sensor using body energy as a power source; Google Patents, 2007.

Chin, F.S.; Zai, P.G.; Lee, C.K.; Ten, T.L.; Kian, S.T. A squeegee coating apparatus for producing a liquid crystal based bio-transducer. Appl. Mech. Mater., 2014, 465, 759-763.

Jayanthi, V.S.A.; Das, A.B.; Saxena, U. Recent advances in biosensor development for the detection of cancer biomarkers. Biosens. Bioelectron., 2016.
[PMID: 27984706]

Salek-Maghsoudi, A.; Vakhshiteh, F.; Torabi, R.; Hassani, S.; Ganjali, M.R.; Norouzi, P.; Hosseini, M.; Abdollahi, M. Recent advances in biosensor technology in assessment of early diabetes biomarkers. Biosens. Bioelectron., 2018, 99, 122-135.
[http://dx.doi.org/10.1016/j.bios.2017.07.047] [PMID: 28750336]

Downing, G. Biomarkers Definitions Working Group.. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther., 2001, 69(3), 89-95.
[http://dx.doi.org/10.1067/mcp.2001.113989] [PMID: 11240971]

Arrambide, G.; Tintore, M.; Espejo, C.; Auger, C.; Castillo, M.; Río, J.; Castilló, J.; Vidal-Jordana, A.; Galán, I.; Nos, C.; Mitjana, R.; Mulero, P.; de Barros, A.; Rodríguez-Acevedo, B.; Midaglia, L.; Sastre-Garriga, J.; Rovira, A.; Comabella, M.; Montalban, X. The value of oligoclonal bands in the multiple sclerosis diagnostic criteria. Brain, 2018, 141(4), 1075-1084.
[http://dx.doi.org/10.1093/brain/awy006] [PMID: 29462277]

Puz, P.; Steposz, A.; Lasek-Bal, A.; Bartoszek, K.; Radecka, P.; Karuga-Pierścieńska, A. Diagnostic methods used in searching for markers of atrophy in patients with multiple sclerosis. Neurol. Res., 2018, 40(2), 110-116.
[http://dx.doi.org/10.1080/01616412.2017.1403729] [PMID: 29168666]

Harris, V.K.; Sadiq, S.A. Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making. Mol. Diagn. Ther., 2009, 13(4), 225-244.
[http://dx.doi.org/10.1007/BF03256329] [PMID: 19712003]

Jain, K.K. Biomarkers of disorders of the nervous system.The Handbook of Biomarkers; Springer, 2017, pp. 463-610.
[http://dx.doi.org/10.1007/978-1-4939-7431-3_14]

Comabella, M.; Montalban, X. Body fluid biomarkers in multiple sclerosis. Lancet Neurol., 2014, 13(1), 113-126.
[http://dx.doi.org/10.1016/S1474-4422(13)70233-3] [PMID: 24331797]

Zetterberg, H.; Teunissen, C. Fluid biomarkers for disease activity in multiple sclerosis; SAGE Publications Sage UK: London, England, 2017.
[http://dx.doi.org/10.1177/1352458517736151]

Barkhof, F.; Simon, J.H.; Fazekas, F.; Rovaris, M.; Kappos, L.; de Stefano, N.; Polman, C.H.; Petkau, J.; Radue, E.W.; Sormani, M.P.; Li, D.K.; O’Connor, P.; Montalban, X.; Miller, D.H.; Filippi, M. MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials. Nat. Rev. Neurol., 2011, 8(1), 13-21.
[http://dx.doi.org/10.1038/nrneurol.2011.190] [PMID: 22143362]

Comi, G.; Radaelli, M.; Soelberg Sørensen, P. Evolving concepts in the treatment of relapsing multiple sclerosis. Lancet, 2017, 389(10076), 1347-1356.
[http://dx.doi.org/10.1016/S0140-6736(16)32388-1] [PMID: 27889192]

Pérez, D.; Gilburd, B.; Cabrera-Marante, Ó.; Martínez-Flores, J.A.; Serrano, M.; Naranjo, L.; Pleguezuelo, D.; Morillas, L.; Shovman, O.; Paz-Artal, E. Predictive autoimmunity using autoantibodies: screening for anti-nuclear antibodies. Clinical Chemistry and Laboratory Medicine; CCLM, 2017.

Linington, C.; Lassmann, H. Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG). J. Neuroimmunol., 1987, 17(1), 61-69.
[http://dx.doi.org/10.1016/0165-5728(87)90031-2] [PMID: 2445777]

Peschl, P.; Bradl, M.; Höftberger, R.; Berger, T.; Reindl, M. Myelin oligodendrocyte glycoprotein: deciphering a target in inflammatory demyelinating diseases. Front. Immunol., 2017, 8, 529.
[http://dx.doi.org/10.3389/fimmu.2017.00529] [PMID: 28533781]

DeMarshall, C.; Goldwaser, E.L.; Sarkar, A.; Godsey, G.A.; Acharya, N.K.; Thayasivam, U.; Belinka, B.A.; Nagele, R.G. Autoantibodies as diagnostic biomarkers for the detection and subtyping of multiple sclerosis. J. Neuroimmunol., 2017, 309, 51-57.
[http://dx.doi.org/10.1016/j.jneuroim.2017.05.010] [PMID: 28601288]

Reindl, M.; Khalil, M.; Berger, T. Antibodies as biological markers for pathophysiological processes in MS. J. Neuroimmunol., 2006, 180(1-2), 50-62.
[http://dx.doi.org/10.1016/j.jneuroim.2006.06.028] [PMID: 16934337]

Dhib-Jalbut, S. Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis; Google Patents, 2017.

de Seze, J. MOG-antibody neuromyelitis optica spectrum disorder: is it a separate disease? Brain, 2017, 140(12), 3072-3075.
[http://dx.doi.org/10.1093/brain/awx292] [PMID: 29194504]

Brettschneider, J.; Jaskowski, T.D.; Tumani, H.; Abdul, S.; Husebye, D.; Seraj, H.; Hill, H.R.; Fire, E.; Spector, L.; Yarden, J.; Dotan, N.; Rose, J.W. Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases. J. Neuroimmunol., 2009, 217(1-2), 95-101.
[http://dx.doi.org/10.1016/j.jneuroim.2009.07.017] [PMID: 19879655]

Filippi, M.; Brück, W.; Chard, D.; Fazekas, F.; Geurts, J.J.G.; Enzinger, C.; Hametner, S.; Kuhlmann, T.; Preziosa, P.; Rovira, À.; Schmierer, K.; Stadelmann, C.; Rocca, M.A. Attendees of the Correlation between Pathological and MRI findings in MS workshop. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol., 2019, 18(2), 198-210.
[http://dx.doi.org/10.1016/S1474-4422(18)30451-4] [PMID: 30663609]

Myronovkij, S.; Negrych, N.; Nehrych, T.; Redowicz, M.J.; Souchelnytskyi, S.; Stoika, R.; Kit, Y. Identification of a 48 kDa form of unconventional myosin 1c in blood serum of patients with autoimmune diseases. Biochem. Biophys. Rep., 2015, 5, 175-179.
[http://dx.doi.org/10.1016/j.bbrep.2015.12.001] [PMID: 28955821]

Winger, R.C.; Zamvil, S.S. Antibodies in multiple sclerosis oligoclonal bands target debris. Proceedings of the National Academy of Sciences, 2016, p. 201609246.
[http://dx.doi.org/10.1073/pnas.1609246113]

D’Ambrosio, A.; Pontecorvo, S.; Colasanti, T.; Zamboni, S.; Francia, A.; Margutti, P. Peripheral blood biomarkers in multiple sclerosis. Autoimmun. Rev., 2015, 14(12), 1097-1110.
[http://dx.doi.org/10.1016/j.autrev.2015.07.014] [PMID: 26226413]

Gandhi, R.; Healy, B.; Gholipour, T.; Egorova, S.; Musallam, A.; Hussain, M.S.; Nejad, P.; Patel, B.; Hei, H.; Khoury, S.; Quintana, F.; Kivisakk, P.; Chitnis, T.; Weiner, H.L. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Ann. Neurol., 2013, 73(6), 729-740.
[http://dx.doi.org/10.1002/ana.23880] [PMID: 23494648]

Kimura, K.; Hohjoh, H.; Fukuoka, M.; Sato, W.; Oki, S.; Tomi, C.; Yamaguchi, H.; Kondo, T.; Takahashi, R.; Yamamura, T. Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis. Nat. Commun., 2018, 9(1), 17.
[http://dx.doi.org/10.1038/s41467-017-02406-2] [PMID: 29295981]

Fenoglio, C.; Ridolfi, E.; Galimberti, D.; Scarpini, E. MicroRNAs as active players in the pathogenesis of multiple sclerosis. Int. J. Mol. Sci., 2012, 13(10), 13227-13239.
[http://dx.doi.org/10.3390/ijms131013227] [PMID: 23202949]

Schöler, N.; Langer, C.; Döhner, H.; Buske, C.; Kuchenbauer, F. Serum microRNAs as a novel class of biomarkers: a comprehensive review of the literature. Exp. Hematol., 2010, 38(12), 1126-1130.
[http://dx.doi.org/10.1016/j.exphem.2010.10.004] [PMID: 20977925]

Sanders, K.A. MicroRNA profiling of multiple sclerosis: from brain to blood., PhD Thesis, Bond University: Gold Coast, April. 2017.

Real-Fernández, F.; Passalacqua, I.; Peroni, E.; Chelli, M.; Lolli, F.; Papini, A.M.; Rovero, P. Glycopeptide-based antibody detection in multiple sclerosis by surface plasmon resonance. Sensors (Basel), 2012, 12(5), 5596-5607.
[http://dx.doi.org/10.3390/s120505596] [PMID: 22778603]

Olaru, A.; Bala, C.; Jaffrezic-Renault, N.; Aboul-Enein, H.Y. Surface plasmon resonance (SPR) biosensors in pharmaceutical analysis. Crit. Rev. Anal. Chem., 2015, 45(2), 97-105.
[http://dx.doi.org/10.1080/10408347.2014.881250] [PMID: 25558771]

Gómara, M.J.; Ercilla, G.; Alsina, M.A.; Haro, I. Assessment of synthetic peptides for hepatitis A diagnosis using biosensor technology. J. Immunol. Methods, 2000, 246(1-2), 13-24.
[http://dx.doi.org/10.1016/S0022-1759(00)00295-7] [PMID: 11121543]

Mayer, K.M.; Hao, F.; Lee, S.; Nordlander, P.; Hafner, J.H. A single molecule immunoassay by localized surface plasmon resonance. Nanotechnology, 2010, 21(25)255503
[http://dx.doi.org/10.1088/0957-4484/21/25/255503] [PMID: 20516579]

Bocková, M. Study of biomolecular interactions by the method of surface plasmon resonance., 2017.

Zhang, X.; Zambrano, A.; Lin, Z-T.; Xing, Y.; Rippy, J.; Wu, T. Immunosensors for biomarker detection in autoimmune diseases. Arch. Immunol. Ther. Exp. (Warsz.), 2017, 65(2), 111-121.
[http://dx.doi.org/10.1007/s00005-016-0419-5] [PMID: 27592176]

Liu, X.; Jiang, H. Construction and potential applications of biosensors for proteins in clinical laboratory diagnosis. Sensors (Basel), 2017, 17(12), 2805.
[http://dx.doi.org/10.3390/s17122805]

Defaus, S.; Gupta, P.; Andreu, D.; Gutiérrez-Gallego, R. Mammalian protein glycosylation--structure versus function. Analyst (Lond.), 2014, 139(12), 2944-2967.
[http://dx.doi.org/10.1039/C3AN02245E] [PMID: 24779027]

Real-Fernández, F.; Rossi, G.; Lolli, F.; Papini, A.M.; Rovero, P. Label-free method for anti-glucopeptide antibody detection in Multiple Sclerosis. MethodsX, 2015, 2, 141-144.
[http://dx.doi.org/10.1016/j.mex.2015.03.004] [PMID: 26150982]

Mansourian, N.; Rahaie, M.; Hosseini, M. A nanobiosensor based on fluorescent DNA-hosted silver nanocluster and HCR amplification for detection of microRNA involved in progression of multiple sclerosis. J. Fluoresc., 2017, 27(5), 1679-1685.
[http://dx.doi.org/10.1007/s10895-017-2105-3] [PMID: 28478551]

Li, Y.; Reichert, W.M. Adapting cDNA microarray format to cytokine detection protein arrays. Langmuir, 2003, 19(5), 1557-1566.
[http://dx.doi.org/10.1021/la026322t]

Peluso, P.; Wilson, D.S.; Do, D.; Tran, H.; Venkatasubbaiah, M.; Quincy, D.; Heidecker, B.; Poindexter, K.; Tolani, N.; Phelan, M.; Witte, K.; Jung, L.S.; Wagner, P.; Nock, S. Optimizing antibody immobilization strategies for the construction of protein microarrays. Anal. Biochem., 2003, 312(2), 113-124.
[http://dx.doi.org/10.1016/S0003-2697(02)00442-6] [PMID: 12531195]

Qiu, J.; Madoz-Gurpide, J.; Misek, D.E.; Kuick, R.; Brenner, D.E.; Michailidis, G.; Haab, B.B.; Omenn, G.S.; Hanash, S. Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens. J. Proteome Res., 2004, 3(2), 261-267.
[http://dx.doi.org/10.1021/pr049971u] [PMID: 15113102]

Levit-Binnun, N.; Lindner, A.B.; Zik, O.; Eshhar, Z.; Moses, E. Quantitative detection of protein arrays. Anal. Chem., 2003, 75(6), 1436-1441.
[http://dx.doi.org/10.1021/ac0261350] [PMID: 12659207]

Rey, I.; Garcia, D.A.; Wheatley, B.A.; Song, W.; Upadhyaya, A. biophysical techniques to study b cell activation: Single-molecule imaging and force measurements. BCell Receptor Signaling; Springer, 2018, pp. 51-68.
[http://dx.doi.org/10.1007/978-1-4939-7474-0_4]

Kingsmore, S.F. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat. Rev. Drug Discov., 2006, 5(4), 310-320.
[http://dx.doi.org/10.1038/nrd2006] [PMID: 16582876]

Han, Z.; Wang, Y.; Duan, X. Biofunctional polyelectrolytes assembling on biosensors - A versatile surface coating method for protein detections. Anal. Chim. Acta, 2017, 964, 170-177.
[http://dx.doi.org/10.1016/j.aca.2017.01.051] [PMID: 28351633]

Gul, O.; Calay, E.; Sezerman, U.; Basaga, H.; Gurbuz, Y. Sandwich-type, antibody microarrays for the detection and quantification of cardiovascular risk markers. Sens. Actuators B Chem., 2007, 125(2), 581-588.
[http://dx.doi.org/10.1016/j.snb.2007.03.005]

Mirnics, K.; Pevsner, J. Progress in the use of microarray technology to study the neurobiology of disease. Nat. Neurosci., 2004, 7(5), 434-439.
[http://dx.doi.org/10.1038/nn1230] [PMID: 15114354]

Eggleton, P.; Smerdon, G.R.; Holley, J.E.; Gutowski, N.J. Manipulation of Oxygen and Endoplasmic Reticulum Stress Factors as Possible Interventions for Treatment of Multiple Sclerosis: Evidence for and Against.Multiple Sclerosis: Bench to Bedside; Springer, 2017, pp. 11-27.
[http://dx.doi.org/10.1007/978-3-319-47861-6_2]

Hendrickx, D.A.E.; van Scheppingen, J.; van der Poel, M.; Bossers, K.; Schuurman, K.G.; van Eden, C.G.; Hol, E.M.; Hamann, J.; Huitinga, I. gene expression Profiling of Multiple sclerosis Pathology identifies early Patterns of Demyelination surrounding chronic active lesions. Front. Immunol., 2017, 8, 1810.
[http://dx.doi.org/10.3389/fimmu.2017.01810] [PMID: 29312322]

Lock, C.B.; Heller, R.A. Gene microarray analysis of multiple sclerosis lesions. Trends Mol. Med., 2003, 9(12), 535-541.
[http://dx.doi.org/10.1016/j.molmed.2003.10.008] [PMID: 14659468]

Quintana, F.J.; Farez, M.F.; Viglietta, V.; Iglesias, A.H.; Merbl, Y.; Izquierdo, G.; Lucas, M.; Basso, A.S.; Khoury, S.J.; Lucchinetti, C.F.; Cohen, I.R.; Weiner, H.L. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc. Natl. Acad. Sci. USA, 2008, 105(48), 18889-18894.
[http://dx.doi.org/10.1073/pnas.0806310105] [PMID: 19028871]

Mathur, D.; Riffo-Campos, A.L.; Castillo, J.; Haines, J.D.; Vidaurre, O.G.; Zhang, F.; Coret-Ferrer, F.; Casaccia, P.; Casanova, B.; Lopez-Rodas, G. Bioenergetic Failure in Rat Oligodendrocyte Progenitor Cells Treated with Cerebrospinal Fluid Derived from Multiple Sclerosis Patients. Front. Cell. Neurosci., 2017, 11, 209.
[http://dx.doi.org/10.3389/fncel.2017.00209] [PMID: 28775680]

Peterlin, B.; Maver, A.; Lovro, V.; Lovrečić, L. Genetics and Epigenetics of Multiple Sclerosis.Epigenetics and Gene Expression in Cancer, Inflammatory and Immune Diseases; Springer, 2017, pp. 169-192.
[http://dx.doi.org/10.1007/978-1-4939-6743-8_11]

Whitney, L.W.; Becker, K.G.; Tresser, N.J.; Caballero-Ramos, C.I.; Munson, P.J.; Prabhu, V.V.; Trent, J.M.; McFarland, H.F.; Biddison, W.E. Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays. Ann. Neurol., 1999, 46(3), 425-428.
[http://dx.doi.org/10.1002/1531-8249(199909)46:3<425:AID-ANA22>3.0.CO;2-O] [PMID: 10482277]

Whitney, L.W.; Ludwin, S.K.; McFarland, H.F.; Biddison, W.E. Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions. J. Neuroimmunol., 2001, 121(1-2), 40-48.
[http://dx.doi.org/10.1016/S0165-5728(01)00438-6] [PMID: 11730938]

Fumagalli, M.; Lecca, D.; Coppolino, G.T.; Parravicini, C.; Abbracchio, M.P. Pharmacological Properties and Biological Functions of the GPR17 Receptor, a Potential Target for Neuro-Regenerative Medicine. Adv. Exp. Med. Biol., 2017, 1051, 169-192.
[http://dx.doi.org/10.1007/5584_2017_92] [PMID: 28828731]

Liu, G.; Hu, Y.; Jin, S.; Jiang, Q. Genetic variant rs763361 regulates multiple sclerosis CD226 gene expression. Proceedings of the National Academy of Sciences, 2017, p. 201618520.
[http://dx.doi.org/10.1073/pnas.1618520114]

Dutta, R.; Trapp, B.D. Gene expression profiling in multiple sclerosis brain. Neurobiol. Dis., 2012, 45(1), 108-114.
[http://dx.doi.org/10.1016/j.nbd.2010.12.003] [PMID: 21147224]

Elshal, M.F.; McCoy, J.P. Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods, 2006, 38(4), 317-323.
[http://dx.doi.org/10.1016/j.ymeth.2005.11.010] [PMID: 16481199]

Nolan, J.P.; Sklar, L.A. Suspension array technology: evolution of the flat-array paradigm. Trends Biotechnol., 2002, 20(1), 9-12.
[http://dx.doi.org/10.1016/S0167-7799(01)01844-3] [PMID: 11742671]

Mucksová, J.; Chalupský, K.; Plachý, J.; Kalina, J.; Rachacová, P.; Staněk, O.; Trefil, P. Simultaneous detection of chicken cytokines in plasma samples using the Bio-Plex assay. Poult. Sci., 2018, 97(4), 1127-1133.
[http://dx.doi.org/10.3382/ps/pex411] [PMID: 29340698]

Cretich, M.; Sola, L.; Gagni, P.; Chiari, M. Novel fluorescent microarray platforms: a case study in neurodegenerative disorders. Expert Rev. Mol. Diagn., 2013, 13(8), 863-873.
[http://dx.doi.org/10.1586/14737159.2013.849574] [PMID: 24151850]

Luo, D.; Fu, J. Identifying characteristic miRNAs-genes and risk pathways of multiple sclerosis based on bioinformatics analysis. Oncotarget, 2018, 9(4), 5287-5300.
[http://dx.doi.org/10.18632/oncotarget.23866] [PMID: 29435179]

Rödiger, S.; Liebsch, C.; Schmidt, C.; Lehmann, W.; Resch-Genger, U.; Schedler, U.; Schierack, P. Nucleic acid detection based on the use of microbeads: a review. Mikrochim. Acta, 2014, 181(11-12), 1151-1168.
[http://dx.doi.org/10.1007/s00604-014-1243-4]

Zhou, H.; Liu, J.; Xu, J-J.; Zhang, S-S.; Chen, H-Y. Optical nano-biosensing interface via nucleic acid amplification strategy: construction and application. Chem. Soc. Rev., 2018, 47(6), 1996-2019.
[http://dx.doi.org/10.1039/C7CS00573C] [PMID: 29446429]

Braeckmans, K.; De Smedt, S.C.; Leblans, M.; Pauwels, R.; Demeester, J. Encoding microcarriers: present and future technologies. Nat. Rev. Drug Discov., 2002, 1(6), 447-456.
[http://dx.doi.org/10.1038/nrd817] [PMID: 12119746]

Rödiger, S.; Schierack, P.; Böhm, A.; Nitschke, J.; Berger, I.; Frömmel, U.; Schmidt, C.; Ruhland, M.; Schimke, I.; Roggenbuck, D. A highly versatile microscope imaging technology platform for the multiplex real-time detection of biomolecules and autoimmune antibodies.Molecular diagnostics; Springer, 2012, pp. 35-74.
[http://dx.doi.org/10.1007/10_2011_132]

Telford, W.G. Analysis of UV-excited fluorochromes by flow cytometry using near-ultraviolet laser diodes. Cytometry A, 2004, 61(1), 9-17.
[http://dx.doi.org/10.1002/cyto.a.20032] [PMID: 15351984]

Jun, B-H.; Rho, C.; Byun, J-W.; Kim, J-H.; Chung, W-J.; Kang, H.; Park, J.; Cho, S.H.; Kim, B.G.; Lee, Y-S. Multilayer fluorescence optically encoded beads for protein detection. Anal. Biochem., 2010, 396(2), 313-315.
[http://dx.doi.org/10.1016/j.ab.2009.05.052] [PMID: 19766091]

Telford, W.G. Overview of Lasers for Flow Cytometry.Flow Cytometry Protocols; Springer, 2018, pp. 447-479.
[http://dx.doi.org/10.1007/978-1-4939-7346-0_19]

Yingyongnarongkul, B.E.; How, S-E.; Díaz-Mochón, J.J.; Muzerelle, M.; Bradley, M. Parallel and multiplexed bead-based assays and encoding strategies. Comb. Chem. High Throughput Screen., 2003, 6(7), 577-587.
[http://dx.doi.org/10.2174/138620703771981179] [PMID: 14683488]

Jun, B-H.; Kim, J-H.; Park, H.; Kim, J-S.; Yu, K-N.; Lee, S-M.; Choi, H.; Kwak, S-Y.; Kim, Y-K.; Jeong, D.H.; Cho, M.H.; Lee, Y.S. Surface-enhanced Raman spectroscopic-encoded beads for multiplex immunoassay. J. Comb. Chem., 2007, 9(2), 237-244.
[http://dx.doi.org/10.1021/cc0600831] [PMID: 17298100]

Pei, X.; Yin, H.; Lai, T.; Zhang, J.; Liu, F.; Xu, X.; Li, N. Multiplexed Detection of Attomoles of Nucleic Acids Using Fluorescent Nanoparticle Counting Platform. Anal. Chem., 2018, 90(2), 1376-1383.
[http://dx.doi.org/10.1021/acs.analchem.7b04551] [PMID: 29226673]

Jun, B-H.; Kang, H.; Lee, Y-S.; Jeong, D.H. Fluorescence-based multiplex protein detection using optically encoded microbeads. Molecules, 2012, 17(3), 2474-2490.
[http://dx.doi.org/10.3390/molecules17032474] [PMID: 22382526]

Horák, D.; Hlídková, H.; Kit, Y.; Antonyuk, V.; Myronovsky, S.; Stoika, R. Magnetic poly(2-hydroxyethyl methacrylate) microspheres for affinity purification of monospecific anti-p46 kDa/Myo1C antibodies for early diagnosis of multiple sclerosis patients. Biosci. Rep., 2017, 37(2)BSR20160526
[http://dx.doi.org/10.1042/BSR20160526] [PMID: 28351895]

Byström, S.; Ayoglu, B.; Häggmark, A.; Mitsios, N.; Hong, M-G.; Drobin, K.; Forsström, B.; Fredolini, C.; Khademi, M.; Amor, S.; Uhlén, M.; Olsson, T.; Mulder, J.; Nilsson, P.; Schwenk, J.M. Affinity proteomic profiling of plasma, cerebrospinal fluid, and brain tissue within multiple sclerosis. J. Proteome Res., 2014, 13(11), 4607-4619.
[http://dx.doi.org/10.1021/pr500609e] [PMID: 25231264]

Dunbar, S.A. Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection. Clin. Chim. Acta, 2006, 363(1-2), 71-82.
[http://dx.doi.org/10.1016/j.cccn.2005.06.023] [PMID: 16102740]

Häggmark, A.; Byström, S.; Ayoglu, B.; Qundos, U.; Uhlén, M.; Khademi, M.; Olsson, T.; Schwenk, J.M.; Nilsson, P. Antibody-based profiling of cerebrospinal fluid within multiple sclerosis. Proteomics, 2013, 13(15), 2256-2267.
[http://dx.doi.org/10.1002/pmic.201200580] [PMID: 23696371]

Luo, X.; Davis, J.J. Electrical biosensors and the label free detection of protein disease biomarkers. Chem. Soc. Rev., 2013, 42(13), 5944-5962.
[http://dx.doi.org/10.1039/c3cs60077g] [PMID: 23615920]

La Belle, J.T.; Gerlach, J.Q.; Svarovsky, S.; Joshi, L. Label-free impedimetric detection of glycan-lectin interactions. Anal. Chem., 2007, 79(18), 6959-6964.
[http://dx.doi.org/10.1021/ac070651e] [PMID: 17658764]

Bhavsar, K.; Fairchild, A.; Alonas, E.; Bishop, D.K.; La Belle, J.T.; Sweeney, J.; Alford, T.L.; Joshi, L. A cytokine immunosensor for Multiple Sclerosis detection based upon label-free electrochemical impedance spectroscopy using electroplated printed circuit board electrodes. Biosens. Bioelectron., 2009, 25(2), 506-509.
[http://dx.doi.org/10.1016/j.bios.2009.07.017] [PMID: 19683426]

Derkus, B.; Emregul, E.; Yucesan, C.; Cebesoy Emregul, K. Myelin basic protein immunosensor for multiple sclerosis detection based upon label-free electrochemical impedance spectroscopy. Biosens. Bioelectron., 2013, 46, 53-60.
[http://dx.doi.org/10.1016/j.bios.2013.01.060] [PMID: 23500477]